BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 167571)

  • 1. A retrospective study of clinical, physiologic and immunologic changes in workers exposed to toluene diisocyanate.
    Porter CV; Higgins RL; Scheel LD
    Am Ind Hyg Assoc J; 1975 Mar; 36(3):159-68. PubMed ID: 167571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Respiratory effects in toluene diisocyanate manufacture: a multidisciplinary approach.
    Weill H; Salvaggio J; Neilson A; Butcher B; Ziskind M
    Environ Health Perspect; 1975 Jun; 11():101-8. PubMed ID: 170075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prospective and immunologic study of factory workers exposed to TDI (toluene diisocyanate).
    Duce F; de Gregorio MA; PĂ©rez J; Portillo JR; Pascual G; Alfonso ER
    Allergol Immunopathol (Madr); 1988; 16(3):139-44. PubMed ID: 2845764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longitudinal study of workers employed in the manufacture of toluene-diisocyanate.
    Butcher BT; Jones RN; O'Neil CE; Glindmeyer HW; Diem JE; Dharmarajan V; Weill H; Salvaggio JE
    Am Rev Respir Dis; 1977 Sep; 116(3):411-21. PubMed ID: 71003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concentration-dependent immunologic response to toluene diisocyanate (TDI) following inhalation exposure.
    Karol MH
    Toxicol Appl Pharmacol; 1983 Apr; 68(2):229-41. PubMed ID: 6304938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tolyl-specific IgE antibodies in workders with hypersensitivity to toluene diisocyanate.
    Karol MH; Ioset HH; Alarie YC
    Am Ind Hyg Assoc J; 1978 Jun; 39(6):454-8. PubMed ID: 210646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toluene diisocyanate-induced asthma without airway hyperresponsiveness.
    Mapp CE; Dal Vecchio L; Boschetto P; De Marzo N; Fabbri LM
    Eur J Respir Dis; 1986 Feb; 68(2):89-95. PubMed ID: 3009212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exposures to toluene diisocyanate (TDI) in polyurethane foam plants.
    Rakow AB; Baier EJ
    HSMHA Health Rep; 1971 Jul; 86(7):663-6. PubMed ID: 5147299
    [No Abstract]   [Full Text] [Related]  

  • 9. [Comparison of stationary and person-bound measurements of toluene diisocyanate in workrooms of a polyurethane foam-producing plant].
    Schaffernicht H; Lange P
    Z Gesamte Hyg; 1985 Jun; 31(6):373-5. PubMed ID: 2994309
    [No Abstract]   [Full Text] [Related]  

  • 10. Presence of tolyl-specific IgE and absence of IgG antibodies in workers exposed to toluene diisocyanate.
    Karol MH; Riley EJ; Alarie Y
    J Environ Sci Health C; 1979; 13(3):221-32. PubMed ID: 233473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serologic test for toluene diisocyanate (TDI) antibodies.
    Karol MH; Alarie YC
    J Occup Med; 1978 Jun; 20(6):383. PubMed ID: 209159
    [No Abstract]   [Full Text] [Related]  

  • 12. Environmental characterization of toluene diisocyanate (TDI) in a manufacturing plant.
    Dharmarajan V; Weil H; Self CW
    Am Ind Hyg Assoc J; 1978 May; 39(5):414-8. PubMed ID: 209683
    [No Abstract]   [Full Text] [Related]  

  • 13. Warfarin binding to plasma of workers exposed to toluene diisocyanate.
    Bachmann K; Shapiro R; Forney RB
    Int J Clin Pharmacol Ther Toxicol; 1982 Feb; 20(2):47-50. PubMed ID: 6277811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toluene diisocyanate.
    IARC Monogr Eval Carcinog Risk Chem Hum; 1986; 39():287-323. PubMed ID: 3023233
    [No Abstract]   [Full Text] [Related]  

  • 15. Respiratory function study of Nigerian workers in a TDI-based foam plant.
    Oleru UG
    Am Ind Hyg Assoc J; 1980 Aug; 41(8):595-9. PubMed ID: 6250391
    [No Abstract]   [Full Text] [Related]  

  • 16. Development and loss of toluene diisocyanate reactivity: immunologic, pharmacologic, and provocative challenge studies.
    Butcher BT; O'Neil CE; Reed MA; Salvaggio JE; Weill H
    J Allergy Clin Immunol; 1982 Oct; 70(4):231-5. PubMed ID: 6288789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemical hypersusceptibility.
    Reinhardt CF
    J Occup Med; 1978 May; 20(5):319-22. PubMed ID: 206676
    [No Abstract]   [Full Text] [Related]  

  • 18. Dermal contact with toluene diisocyanate (TDI) produces respiratory tract hypersensitivity in guinea pigs.
    Karol MH; Hauth BA; Riley EJ; Magreni CM
    Toxicol Appl Pharmacol; 1981 Apr; 58(2):221-30. PubMed ID: 6264649
    [No Abstract]   [Full Text] [Related]  

  • 19. A technique for dynamic calibration of a continuous toluene diisocyanate monitor.
    Neilson A; Booth KS
    Am Ind Hyg Assoc J; 1975 Mar; 36(3):169-71. PubMed ID: 167572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of respiratory injury by TDI (toluene disocyanate).
    Vanert M; Battigelli MC
    Ann Allergy; 1975 Sep; 35(3):142-7. PubMed ID: 51599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.